UREA AND SULFONAMIDE DERIVATIVES AS HUMAN HELICASE DDX3 INHIBITORS USEFUL IN THE TREATMENT OF VIRAL DISEASES
The present invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, in particular for the treatment of viral diseases..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 13. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
MEYERHANS ANDREAS [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-13, Last update posted on www.tib.eu: 2023-11-30, Last updated: 2023-12-08 |
|---|
| Patentnummer: |
EP3256461 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA004222644 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA004222644 | ||
| 003 | DE-627 | ||
| 005 | 20231208115222.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA004222644 | ||
| 035 | |a (EPA)EP3256461 | ||
| 035 | |a (EPA)55453128 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a MEYERHANS ANDREAS |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a UREA AND SULFONAMIDE DERIVATIVES AS HUMAN HELICASE DDX3 INHIBITORS USEFUL IN THE TREATMENT OF VIRAL DISEASES |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-13, Last update posted on www.tib.eu: 2023-11-30, Last updated: 2023-12-08 | ||
| 520 | |a The present invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, in particular for the treatment of viral diseases. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MARTINEZ DE LA SIERRA MIGUEL-ANGEL |4 aut | |
| 700 | 0 | |a BRAI ANNALAURA |4 aut | |
| 700 | 0 | |a FAZI ROBERTA |4 aut | |
| 700 | 0 | |a TINTORI CRISTINA |4 aut | |
| 700 | 0 | |a BOTTA MAURIZIO |4 aut | |
| 700 | 0 | |a ARAQUE JOSÉ-ESTÉ |4 aut | |
| 700 | 0 | |a MARTINEZ JAVIER |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 13. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:13 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/55453128/publication/EP3256461A1?q=EP3256461 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 13 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 13 |c 09 | ||